News

Raising Awareness and Improving Treatment of Pulmonary Hypertension

Few health challenges are as well-publicized as high blood pressure, a topic that has become all too familiar, appearing everywhere from the daily news to medical conferences. And being so familiar, it is easy to overlook the fact that most of this attention has been devoted to a problem that stems

Heart Institute Programs Identified as Leading Practices

Like most health care organizations in Canada, the University of Ottawa Heart Institute undergoes regular review by Accreditation Canada. This rigorous process assesses hospitals against more than 900 standards and criteria. As part of its 2013 accreditation, Accreditation Canada identified four

CCC/Vascular 2013: Program Guide

This year, the Canadian Cardiovascular Congress is part of an even larger event called Vascular 2013, combining parallel conferences dedicated to cardiovascular disease, hypertension, diabetes and stroke. The University of Ottawa Heart Institute has program items in all of these—nearly 120 in all

Landmark Stem Cell Clinical Trial Opens

In July, the first patient in a landmark clinical trial received treatment at the University of Ottawa Heart Institute. The new ENACT-AMI (Enhanced Angiogenic Cell Therapy—Acute Myocardial Infarction) trial, led by the Ottawa Hospital Research Institute, is designed to test whether genetically

UOHI at the Canadian Cardiovascular Congress/Vascular 2013

This year, the Canadian Cardiovascular Congress (CCC) was part of an even larger event called Vascular 2013 that added parallel conferences dedicated to hypertension, diabetes and stroke. The University of Ottawa Heart Institute had program items in all of these subject areas— nearly 120 in all

American Heart Association Scientific Sessions 2013

The American Heart Association Scientific Sessions is the largest conference for cardiovascular science and medicine in the world. The staff of the University of Ottawa Heart Institute is once again responsible for many expert clinical talks and research presentations. This guide highlights those

CCC 2013: Diabetes Management in a Cardiac Care Setting

Diabetes is a major contributing factor for heart disease. Diabetes patients are two to three times more likely to develop cardiovascular disease than the general population. With the condition widely undertreated and diabetes rates growing, cardiovascular professionals are looking to stem the flow

CCC 2013: Don’t Fear the Exercise Prescription

Regular physical activity is one of the most beneficial things a person can do to prevent heart disease or support their rehabilitation after a heart attack or cardiac surgery. A study recently published in the British Medical Journal found that exercise can be as good or better than drug therapy

CCC 2013: Aging Blood Vessels and the Role of Biomarkers

In two lively talks, Peter Liu, MD, Scientific Director of the University of Ottawa Heart Institute, took a big picture point of view. In his plenary presentation to the Vascular Summit, Dr. Liu highlighted the inextricable link between vascular health and aging. Vascular aging leads to vascular

CCC 2013: Type D Personality and Cardiac Rehabilitation

People with Type D personality are distressed. They tend to experience negative emotions and keep these emotions inside, not sharing them with others. Personality traits such as these are considered stable over time. As would be expected, Type D individuals with cardiovascular disease have a poor